Back to Journals » Open Access Journal of Clinical Trials » Volume 12
Study Protocol
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,045 | Dovepress* | 6,045+ | 1,260 | 7,305 | |
Totals | 6,045 | 1,260 | 7,305 | ||
*Since 7 January 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
10 | 0 | 0 | 0 | 5 | 5 |
View citations on Google Scholar